iconEarnings Announcement Before Market Open

Krystal Biotech Inc KRYS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
156.94UNCH (UNCH)
Volume
3,236
Close
156.94quote price arrow down-4.16 (-2.58%)
Volume
759,936
52 week range
83.38 - 189.97
Loading...
  • Open145.50
  • Day High159.18
  • Day Low144.00
  • Prev Close161.10
  • 52 Week High189.97
  • 52 Week High Date03/05/24
  • 52 Week Low83.38
  • 52 Week Low Date05/08/23

Key Stats

  • Market Cap4.475B
  • Shares Out28.51M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change26.5

KEY STATS

  • Open145.50
  • Day High159.18
  • Day Low144.00
  • Prev Close161.10
  • 52 Week High189.97
  • 52 Week High Date03/05/24
  • 52 Week Low83.38
  • 52 Week Low Date05/08/23
  • Market Cap4.475B
  • Shares Out28.51M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change26.5

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)1,773.33
  • Fwd P/E (NTM)86.42
  • EBITDA (TTM)-91.288M
  • ROE (TTM)1.68%
  • Revenue (TTM)50.699M
  • Gross Margin (TTM)93.90%
  • Net Margin (TTM)21.56%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Krystal Biotech Inc

 

Profile

MORE
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. It is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include VYJUVEK, KB407, KB408, KB707, KB105, KB104, KB104, and KB301. Its commercial product VYJUVEK is a non-invasive, topical, redo sable gene therapy designed to deliver two...
Krish Krishnan
Chairman of the Board, President, Chief Executive Officer
Kathryn Romano CPA
Chief Accounting Officer
Address
2100 Wharton St Ste 701
Pittsburgh, PA
15203-1973
United States

Top Peers

SYMBOLLASTCHG%CHG
ALPN
Alpine Immune Sciences Inc
64.60UNCHUNCH
MDGL
Madrigal Pharmaceuticals Inc
235.57+5.73+2.49%
NUVL
Nuvalent Inc
69.25-1.10-1.56%
BBIO
BridgeBio Pharma Inc
28.09+0.26+0.93%
IBRX
Immunitybio Inc
7.81-1.34-14.64%